[Role of local immunity in invasive pulmonary aspergillosis]

D Aldebert1, C Pinel, J P Brion

  • 1Laboratoire Interactions cellulaires Parasites-Hôte EA-2940, Faculté de Médecine-Pharmacie, Université Joseph Fourier, Grenoble I, La Tronche. Delphine.Aldebert@ujf-grenoble.fr

Presse Medicale (Paris, France : 1983)
|October 18, 2001
PubMed

Insights

Invasive aspergillosis (IA), caused by Aspergillus fumigatus, is a major cause of mortality, especially in immunocompromised patients. Understanding the complex immune response is key to improving IA prevention and treatment.

Area of Science:

  • Immunology
  • Mycology
  • Infectious Diseases

Background:

  • Inhalation of fungal spores, particularly Aspergillus fumigatus, can lead to severe infections and inflammation.
  • Invasive aspergillosis (IA) is a significant cause of mortality, particularly in immunocompromised individuals like organ transplant recipients and AIDS patients.

Purpose of the Study:

  • To synthesize current knowledge on the immune response against Aspergillus fumigatus in the context of invasive aspergillosis.
  • To explore the complex fungus-host relationships in IA to inform prevention and treatment strategies.

Main Methods:

  • This review synthesizes existing research on the immunological mechanisms involved in combating Aspergillus fumigatus.
  • It examines both non-specific and acquired immunity components.

Main Results:

  • Non-specific immunity, involving anatomical barriers, humoral factors, and phagocytic cells, plays a crucial role in defense against A. fumigatus.
  • Acquired immunity, mediated by T-cell subsets and cytokines, also contributes to the elimination of the fungus.
  • The interaction between Aspergillus fumigatus and the host immune system is intricate.

Conclusions:

  • A comprehensive understanding of the immune response to Aspergillus fumigatus is essential for developing effective strategies against invasive aspergillosis.
  • Further research into fungus-host interactions holds promise for improved prevention and treatment of IA.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...